Nalini Janakiraman - Concepedia

Author

Nalini Janakiraman

Also Known As

Alford, S.H., Casey, G., De Roos, Anneclaire J., N Janakiraman, N. JANAKIRAMAN, N. Janakiraman, Nalini Janakiraman, SR Williamson

133

Publications

5.5K

Citations

H-Index

Concepts

All Affiliations

Henry Ford Hospital Henry Ford Health System The Barbara Ann Karmanos Cancer Institute Fox Chase Cancer Center University of California, Los Angeles

About

Nalini Janakiraman is an author at Henry Ford Hospital specializing in medicine, immunology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	1.4K
2	Cell Biology	6	6	328
3	Health Sciences	5	5	163
4	Biomedical Engineering	1	1	38
5	Blood Transplantation	1	1	22

Nalini Janakiraman

Publications

5.3K

Citations

H-Index

Page 1

	Year	Citations
IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma David G. Maloney, Antonio J Grillo-López, Christine A. White, Blood	1997	1.7K
Human marrow stromal cell therapy for stroke in rat Y. Li, J. Chen, Xinyuan Chen, Neurology	2002	869
Phase I/II Trial of IDEC-Y2B8 Radioimmunotherapy for Treatment of Relapsed or Refractory CD20<sup>+</sup>B-Cell Non-Hodgkin's Lymphoma Thomas E. Witzig, Christine A. White, Gregory A. Wiseman, Journal of Clinical Oncology	1999	538
Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma Lawrence D. Piro, Christine A. White, A.J. Grillo-López, Annals of Oncology Lymphoid NeoplasiaMedicineImmunologyAnti-cd20 Monoclonal AntibodyImmune Checkpoint Inhibitor	1999	368
Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production11Abbreviations: CTLs, cytotoxic T lymphocytes; LAK cells, lymphokine activated killer cells; IL-2, interleukin-2; IFN-γ, interferon-gamma; TNF-α, tumor necrosis factor-α NF-κB, nuclear factor kappa B; Con A, concanavalin A; HBSS, Hanks’ balanced salt solution; DTT, dithiothreitol; PMSF, phenylmethylsulfonyl fluoride; RT-PCR, reverse transcription-polymerase chain reaction; LPS, lipopolysaccharide; and EMSA, electrophoretic mobility shift assay. Xiaohua Gao, Yong Xu, Nalini Janakiraman, Biochemical Pharmacology	2001	243
Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells. Dorrah Deeb, Yong Xu, Hao Jiang, PubMed Anti-inflammatoryChemoprevention StrategyMedicineNutraceutical IngredientApoptosis	2003	158
IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma David G. Maloney, Antonio J Grillo-López, Christine A. White, Blood	1997	156
Disparate In Vitro and In Vivo Antileukemic Effects of Resveratrol, a Natural Polyphenolic Compound Found in Grapes Xiaohua Gao, Yong Xu, George Divine, Journal of Nutrition Wine PerceptionPharmacologyPhytopharmacologyPhytochemicalPhytochemistry	2002	125
Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells. Yuxin Xu, Kirit Pindolia, Nalini Janakiraman, PubMed InflammationCytokineTranscriptional RegulationNf-kb Dna-binding ActivityMcp-1/je Gene	1998	123
Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging Gautam Sc, YX Xu, Mariquit Dumaguin, Bone Marrow Transplantation Hematological MalignancyChemoprevention StrategyMedicineMalignant Blood DisorderHematology	2000	114

Page 1